Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid

Cardiovascular disease (CVD) represents the leading cause of mortality worldwide. Lifestyle modifications, along with low-density lipoprotein cholesterol (LDL-C) reduction, remain the highest priorities in CVD risk management. Among lipid-lowering agents, statins are most effective in LDL-C reductio...

Descripción completa

Detalles Bibliográficos
Autores principales: Moutzouri, Elisavet, Kei, Anastazia, Elisaf, Moses S, Milionis, Haralampos J
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922314/
https://www.ncbi.nlm.nih.gov/pubmed/20730069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922314/
https://www.ncbi.nlm.nih.gov/pubmed/20730069

Ejemplares similares